$ABBV Recent News Microsoft, Amazon, Starbucks are

New Post Public Reply Private Reply Replies (0) Message Board

May 9, 2014 at 11:07 AM

$ABBV Recent News

Microsoft, Amazon, Starbucks are stocks to watch 8:46 a.m. April 25, 2014 - Sue Chang
AbbVie shares rise after earnings top forecasts 8:10 a.m. April 25, 2014 - Ben Eisen
AbbVie shares rise 2.4% premarket on earnings 8:03 a.m. April 25, 2014 - Ben Eisen
Abbvie Q1 EPS tops forecast of $0.68 8:02 a.m. April 25, 2014 - Ben Eisen
AbbVie reaffirms 2014 adj EPS range of $3 to $3.10 8:00 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 sales rise to $4.56 bln vs $4.33 bln 8:00 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 EPS edges up to $0.61; Adjusted: $0.71 8:00 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 profit rises to $980 mln vs $968 mln 8:00 a.m. April 25, 2014 - Ben Eisen
I have no qualms about taking Gilead’s $84,000 drug 7:30 a.m. April 22, 2014 - Tim Mullaney
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Abbott Labs profit falls 31% 8:45 a.m. April 16, 2014 - MarketWatch.com
First Solar tops S&P 500; Alcoa up ahead of earnings 3:52 p.m. April 8, 2014 - Sue Chang
Gilead: Hepatitis C Japan trial meets endpoint 3:44 a.m. April 3, 2014 - MarketWatch.com
Investors may need to go long if they hope to reap Baxter spinoff rewards 11:40 a.m. March 27, 2014 - Russ Britt
Jobs, winter weather to test record stock levels 7:02 a.m. March 2, 2014 - Wallace Witkowski
Analyst upgrades Gilead, says biotech is 'too good not to own' 3:06 p.m. Feb. 4, 2014 - Russ Britt
More positive tests for hep C drug boost AbbVie and Enanta shares 11:52 a.m. Jan. 31, 2014 - Russ Britt
Stock investors trash market darlings, face Apple, Fed 9:01 a.m. Jan. 26, 2014 - Wallace Witkowski
Mounting optimism for hepatitis C drug boosts Gilead to lead S&P 500 4:09 p.m. Jan. 16, 2014 - Russ Britt
Investors warm up to Gilead's test results; shares climb 5% by close 5:49 p.m. Dec. 18, 2013 - Russ Britt

April Aristocrat Dogs 7% - 9% Upsides Led By Consumer Goods And Services 12:45 p.m. May 8, 2014 - Seeking Alpha
Abbvie submits marketing app to EMA 7:36 a.m. May 8, 2014 - Seeking Alpha
3 Stocks Raising The Drugs Industry Higher 1:02 p.m. May 7, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ABBV WCG CFN FMS 8:45 a.m. May 7, 2014 - InvestorPlace.com
UPDATE: Morgan Stanley Upgrades AbbVie 7:46 a.m. May 7, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More 7:27 a.m. May 7, 2014 - 247WallSt.com
Enanta Pharmaceuticals: A Potential Play On Drug-Resistant Bacteria 4:16 p.m. May 6, 2014 - Seeking Alpha
Gilead Is Set To Grow 11:09 a.m. May 5, 2014 - Seeking Alpha
Why Target Shares Fell Rather Than Rose on CEO Firing 10:27 a.m. May 5, 2014 - 247WallSt.com
Finding Yield In Health Care 2:32 a.m. May 5, 2014 - Seeking Alpha
Two Big Pharma Picks to Buy Now 2:25 a.m. May 3, 2014 - Barrons.com
Medical Devices Face Onslaught Of Pricing Pressure 4:26 p.m. May 2, 2014 - Investors Business Daily
10 Healthcare Dogs Script 9% To 19% April Upsides 10:22 a.m. May 2, 2014 - Seeking Alpha
5 Weird & Unloved ETFs Getting The Job Done 7:05 a.m. May 2, 2014 - InvestorPlace.com
5 Biotech Stocks Ready To Resume Their Rally 5:08 p.m. May 1, 2014 - Barrons.com
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews 5:03 a.m. May 1, 2014 - Zacks.com
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook 5:03 a.m. May 1, 2014 - Zacks.com
Repros Has an Edge on Auxilium 3:02 p.m. April 30, 2014 - Barrons.com
Momenta Pharmaceuticals Has Value In The Sum Of The Drugs 10:35 a.m. April 29, 2014 - Seeking Alpha
Stock Market News for April 29, 2014 - Market News 10:06 a.m. April 29, 2014 - Zacks.com

AbbVie Submits for EU Marketing Authorization its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Chronic Hepatitis C 2:00 a.m. May 8, 2014 - PR Newswire - PRF
Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie 9:00 a.m. May 6, 2014 - PR Newswire - PRF
Approvals from the European Commission and Release of Quarterly Financial Results - Analyst Notes on Merck, Johnson & Johnson, Bristol-Myers Squibb, Teva and AbbVie 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Active Equities Technical Coverage -- Research on Mondelez Intl., Time Warner, AbbVie, and FireEye 4:40 a.m. May 1, 2014 - PR Newswire - PRF
Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014 3:10 p.m. April 28, 2014 - PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard 8:00 a.m. April 28, 2014 - PR Newswire - PRF
AbbVie Reports First-Quarter 2014 Financial Results 7:54 a.m. April 25, 2014 - PR Newswire - PRF
Stocks Close to Announcing their Earnings -- Research on AbbVie, Weyerhaeuser, Tyco Intl., and Colgate-Palmolive 5:11 a.m. April 25, 2014 - PR Newswire - PRF
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie 8:00 a.m. April 24, 2014 - PR Newswire - PRF
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C 8:46 a.m. April 22, 2014 - PR Newswire - PRF
Application Now Open for Students with Cystic Fibrosis for the 2014 AbbVie CF Scholarship 11:00 a.m. April 16, 2014 - PR Newswire - PRF
AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) for Patients with Non-Small Cell Lung Cancer 8:00 a.m. April 15, 2014 - PR Newswire - PRF
AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress™ 1:00 a.m. April 12, 2014 - PR Newswire - PRF
Equities to Watch in the Health Care Sector -- Research on AbbVie, GlaxoSmithKline, AstraZeneca, and Novartis 9:46 a.m. April 9, 2014 - PR Newswire - PRF
AbbVie to Host First-Quarter Earnings Conference Call 8:00 a.m. April 7, 2014 - PR Newswire - PRF
Financial Results, Launches, Adjusted Conversion Rates, Upcoming Presentations, and Stock Movements - Analyst Notes on AbbVie, Chemed, Antares Pharma, Magellan Health Services, and Natus Medical 8:00 a.m. April 3, 2014 - PR Newswire - PRF
AbbVie to Present Detailed Results from Phase III Studies in Patients with Chronic Hepatitis C at the 2014 International Liver Congress™ 5:00 a.m. March 24, 2014 - PR Newswire - PRF
Health Care Sector Equities Technical Commentary -- Research on AbbVie, GlaxoSmithKline, AstraZeneca and Novartis 6:44 p.m. March 21, 2014 - PR Newswire - PRF
AbbVie Initiates New Clinical Trial to Evaluate HUMIRA® (adalimumab) for the Treatment of Fingernail Psoriasis in Patients with Moderate to Severe Chronic Plaque Psoriasis 7:00 a.m. March 20, 2014 - PR Newswire - PRF
Investment Grants, Data Presentations, Clinical Study Results, and Collaborative Programs - Analyst Notes on UnitedHealth Group, Bristol-Myers Squibb, AbbVie, Cigna, and OXiGENE 8:00 a.m. March 14, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vermiculus Unveils VeriIndex: A Game-Changer for Indices

Standing on the Precipice of Index Innovation There’s a seismic shift rumbling through Vermiculus as they roll out their latest brainchild, the VeriIndex. This isn’t just your typical release; it’s the kind of shakeup that slaps you awake like a splash of cold water. Ever since they burst onto the scene in 2020, Vermiculus has been stirring the pot of exchange...

American Lung Association Tackles Indoor Pollution

The Unseen Threat Lurking Indoors When you think about air pollution, your mind probably jumps to smog-choked city streets. But, surprise! The air inside your cozy living room could actually be pulling a fast one on you, being two to five times filthier than what’s outside. Now, that’s a hair-raising thought. A Closer Look at Indoor Air Hazards Folks don’t usually...

VIAVI's 37% NetSecOps Uptick: A Mixed Bag for Firms

Networking and Security: The Clash of the Titans The IT world sure loves mixing and matching its acronyms these days, doesn’t it? VIAVI Solutions, an ace in hybrid network-security operations, just released their 18th annual 'State of the Network' study. Tipping the hat to progress, they've reported a 37% jump in firms that have embraced NetSecOps over the past year....

Moises and SoundCloud Join Forces to Empower Musicians

Paving the Way for Artist Empowerment You ever wake up and feel like the music world just shifted? Like the landscape just got smoother for artists trying to juggle creativity and business without losing their minds? Well, Moises and SoundCloud teaming up might be just that seismic shift. Playing in the Big Leagues with Moises' Creative Suite Let's not fool...

Greenland Energy Board Reshuffle: McIllree Exits

A Change in Greenland Energy's Lineup Well, folks, the wheel keeps turning at Greenland Energy Company (NASDAQ:GLND). Roderick McIllree has decided to step off the Board of Directors' carousel, effective immediately. And nope, there wasn't a classic showdown or any disagreement on the table. This exit is as drama-free as they come—just him stepping aside, leaving the...

European Flavors: A Halloween Food Revolution

Who would've thought Halloween would toss a spin on fine dining? What's usually known for candy corn and spooky costumes has teamed up with European flavors for a night unlike any other. And we're talking more than just trick-or-treating here, folks. A New Kind of Halloween Spread This year, The Charming Taste of Europe has thrown itself into the Halloween festivities,...

Coles Teams Up with Coveo to Boost Online Grocery Shopping

Coles and Coveo: A Tech Partnership Worth Watching Buckle up, folks, because Coles Group Limited has chosen Coveo, the hotshot in AI-relevance, to revamp the online shopping landscape for its grocery business. Let's break down why this matters for both the grocery shopper hustling between work and carbs and the savvy investor eyeing the digital retail frontier. Enhancing...

School Safety: Revamping Response Coordination

Revamp in Emergency Training for School Incidents No longer can schools afford the luxury of uncoordinated chaos during emergencies. Today, the firepower behind the National Center for Integrated Emergency Response (NCIER) comes from the realization that courage alone doesn't cut it. It's about time someone put the pieces together, getting cops, fire, school staff, and...

Top Seedz: Seeds Drive Growth in Crowded Cracker Market

Breaking the Cracker Mold with Seeds Ever thought crackers could be more than just a canvas for cheese? Well, Top Seedz out of Buffalo is redefining the snack aisle with its seed-centric approach. In a whopping $25 billion global cracker market, this woman-owned outfit is carving out its niche by flipping conventional recipes on their heads. They're not just tossing seeds...

Duolingo Faces Class Action: Investors Brace for Impact

Going Beyond Language Learning Hype Listen, it's not every day you wake up to a lawsuit calling out one of those seemingly indestructible tech darlings. Well, Duolingo (NASDAQ: DUOL) is caught in the crosshairs now. They face allegations of pulling the wool over investors' eyes about their monetization and growth tactics. If you snapped up some stock between May 2, 2025,...